IFP Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $116K | Sell |
1,350
-20
| -1% | -$1.75K | ﹤0.01% | 1868 |
|
|
2026
Q1 | $124K | Sell |
1,370
-118
| -8% | -$10.8K | ﹤0.01% | 1691 |
|
|
2025
Q4 | $134K | Sell |
1,488
-349
| -19% | -$33.1K | ﹤0.01% | 1601 |
|
|
2025
Q3 | $181K | Sell |
1,837
-110
| -6% | -$10.9K | ﹤0.01% | 1337 |
|
|
2025
Q2 | $178K | Buy |
1,947
+149
| +8% | +$14.4K | 0.01% | 1327 |
|
|
2025
Q1 | $204K | Sell |
1,798
-948
| -35% | -$101K | 0.01% | 1169 |
|
|
2024
Q4 | $290K | Sell |
2,746
-13
| -0.5% | -$1.4K | 0.01% | 956 |
|
|
2024
Q3 | $298K | Sell |
2,759
-216
| -7% | -$23.6K | 0.01% | 898 |
|
|
2024
Q2 | $323K | Buy |
2,975
+211
| +8% | +$24.9K | 0.01% | 807 |
|
|
2024
Q1 | $365K | Sell |
2,764
-4
| -0.1% | -$500 | 0.02% | 724 |
|
|
2023
Q4 | $337K | Buy |
2,768
+5
| +0.2% | +$558 | 0.02% | 721 |
|
|
2023
Q3 | $310K | Buy |
2,763
+469
| +20% | +$59.6K | 0.01% | 763 |
|
|
2023
Q2 | $334K | Buy |
2,294
+26
| +1% | +$3.53K | 0.01% | 802 |
|
|
2023
Q1 | $144K | Sell |
2,268
-1,988
| -47% | -$250K | 0.01% | 1079 |
|
|
2022
Q4 | $277K | Sell |
4,256
-33
| -0.8% | -$3.83K | 0.01% | 1179 |
|
|
2022
Q3 | $283K | Buy |
4,289
+891
| +26% | +$97.8K | 0.01% | 1228 |
|
|
2022
Q2 | $222K | Hold |
3,398
| – | – | 0.01% | 1225 |
|
|
2022
Q1 | $222K | Buy |
3,398
+1,531
| +82% | +$185K | 0.01% | 1225 |
|
|
2021
Q4 | $231K | Sell |
1,867
-16
| -0.8% | -$2.09K | ﹤0.01% | 887 |
|
|
2021
Q3 | $268K | Buy |
1,883
+610
| +48% | +$89.7K | 0.01% | 818 |
|
|
2021
Q2 | $198K | Buy |
1,273
+778
| +157% | +$126K | ﹤0.01% | 914 |
|
|
2021
Q1 | $76K | Sell |
495
-180
| -27% | -$27.9K | ﹤0.01% | 1287 |
|
|
2020
Q4 | $101K | Buy |
675
+36
| +6% | +$5.08K | ﹤0.01% | 1135 |
|
|
2020
Q3 | $86K | Sell |
639
-72
| -10% | -$9.41K | 0.01% | 1067 |
|
|
2020
Q2 | $80K | Sell |
711
-9
| -1% | -$1.04K | 0.01% | 1011 |
|
|
2020
Q1 | $72K | Sell |
720
-200
| -22% | -$26.2K | 0.01% | 968 |
|
|
2019
Q4 | $135K | Sell |
920
-122
| -12% | -$16.8K | 0.01% | 800 |
|
|
2019
Q3 | $137K | Buy |
+1,042
| New | +$135K | 0.01% | 913 |
|
|
2019
Q1 | $146K | Sell |
1,172
-1,031
| -47% | -$117K | 0.02% | 562 |
|
|
2018
Q4 | $220K | Buy |
2,203
+900
| +69% | +$101K | 0.01% | 828 |
|
|
2018
Q3 | $166K | Sell |
1,303
-76
| -6% | -$9.04K | 0.01% | 1179 |
|
|
2018
Q2 | $149K | Sell |
1,379
-9
| -0.6% | -$980 | 0.01% | 1247 |
|
|
2018
Q1 | $163K | Hold |
1,388
| – | – | 0.01% | 1088 |
|
|
2017
Q4 | $163K | Sell |
1,388
-621
| -31% | -$70.2K | 0.01% | 1095 |
|
|
2017
Q3 | $228K | Sell |
2,009
-130
| -6% | -$15K | 0.01% | 1071 |
|
|
2017
Q2 | $267K | Buy |
2,139
+391
| +22% | +$46.4K | 0.01% | 969 |
|
|
2017
Q1 | $207K | Sell |
1,748
-31
| -2% | -$3.51K | 0.01% | 1101 |
|
|
2016
Q4 | $178K | Buy |
1,779
+151
| +9% | +$16.2K | 0.01% | 1114 |
|
|
2016
Q3 | $206K | Buy |
1,628
+76
| +5% | +$9.39K | 0.01% | 994 |
|
|
2016
Q2 | $181K | Buy |
1,552
+380
| +32% | +$43K | 0.01% | 1022 |
|
|
2016
Q1 | $146K | Sell |
1,172
-35
| -3% | -$3.39K | 0.02% | 562 |
|
|
2015
Q4 | $120K | Buy |
+1,207
| New | +$118K | 0.01% | 1078 |
|
Other funds holding ZBH
IFP Advisors's ZBH Position: Q2 2026 in Review
IFP Advisors reduced its Zimmer Biomet (ZBH) stake by 1.5% in Q2 2026, selling an estimated $1.75K and leaving 1,350 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #1868.
IFP Advisors first reported a position in ZBH in Q4 2015 and has held it in 42 quarters since. The position peaked at $365K in Q1 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- IFP Advisors held 1,350 shares of Zimmer Biomet worth $116K as of Q2 2026.
- IFP Advisors sold 20 Zimmer Biomet shares in Q2 2026, an estimated $1.75K.
- Zimmer Biomet made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #1868 holding.
- IFP Advisors first reported a position in Zimmer Biomet in Q4 2015 and has held it in 42 quarters since.
- IFP Advisors's Zimmer Biomet position peaked at $365K in Q1 2024.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.